RxDoctor Payments Data

John Allen, DO

Family Medicine · Mentor, OHNPI 1215514815

Payments from drug & device makers

$1,877in general payments, 2019–2025

Across 75 payments — averaging $25.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$537
  • Exact Sciences$284
  • Amgen$183
  • Phathom Pharmaceuticals, Inc.$180
  • AbbVie$163
  • Lilly USA, LLC$102
  • plus $427 from 10 others

What the payments were for

  • Food & beverage$1,877100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,877 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$12,273
Medicare patients
86
Services billed
124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin18$29,902
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$19,822
Ventolin HfaAlbuterol Sulfate11$619
Rosuvastatin Calcium37$576
Albuterol Sulfate HfaAlbuterol Sulfate20$333
Metoprolol Succinate18$331
Azelastine Hcl14$327
Omeprazole18$314
Olmesartan Medoxomil16$262
Levothyroxine Sodium19$170
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav22$145
Atorvastatin Calcium19$130
Fluticasone Propionate13$125
Losartan Potassium12$91
Lisinopril12$75

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$82$19,82225 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Mentor

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →